Skip to main content
MarketsReportedMedium
4.9

Peninsula launches €150M continuation fund for Galenicum, retains 20% stake

Peninsula, led by Kline Hill, is reinvesting in Galenicum via a new €150 million continuation vehicle, retaining a 20% stake in the pharma firm known for generic versions of Ozempic and Wegovy. This signals continued private-equity confidence in the GLP-1 generics market, though financial terms and fund structure details remain undisclosed.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Expansiónabout 2 hours agoESCredibility 20%View source

Score Breakdown

Mosaic Score4.9
Model confidence0.5
Significance0.5
Source credibility0.2
Source

Related signals

8 found